SCHEMBL15055352

SCHEMBL15055352

CCCOC(=O)c1cccc(-c2cc(S(=O)(=O)Nc3ccc(C(=O)OC)c(O)c3)sc2Cl)c1

nearest known ligand 0.66

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PFKFB3 Q16875 10/20 0.66
PFKFB4 Q16877 5/20 0.47
ALDH1A1 P00352 5/20 0.44
LMNA P02545 2/20 0.44
HPGD P15428 2/20 0.44
MAPT P10636 2/20 0.40
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
KDM4E B2RXH2 1/20 0.38
POLB P06746 1/20 0.38
GAA P10253 1/20 0.38
MAPK1 P28482 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
PKM P14618 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
ROCK2 O75116 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
ALPL P05186 1/20 0.37
PLAU P00749 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15056048 0.91 PFKFB3 (0.75) PFKFB3PFKFB4POLBSMN1; SMN2PLAU
SCHEMBL15055734 0.88 PFKFB3 (0.70) PFKFB3PFKFB4ALDH1A1MAPTPOLB
SCHEMBL15056062 0.88 PFKFB3 (0.75) PFKFB3PFKFB4ALDH1A1HPGDMEN1
SCHEMBL15055350 0.86 PFKFB3 (0.87) PFKFB3PFKFB4MAPTPOLBSMN1; SMN2
SCHEMBL15056582 0.86 PFKFB3 (0.84) PFKFB3PFKFB4ALDH1A1HPGDMEN1
SCHEMBL15055211 0.85 PFKFB3 (0.67) PFKFB3PFKFB4
SCHEMBL15055572 0.83 PFKFB3 (0.63) PFKFB3PFKFB4ALDH1A1LMNAMAPT
SCHEMBL15055918 0.82 PFKFB3 (0.57) PFKFB3PFKFB4ALDH1A1LMNAHPGD
SCHEMBL15055521 0.81 PFKFB3 (0.59) PFKFB3ALDH1A1HPGDMAPTMEN1
SCHEMBL15056052 0.80 PFKFB3 (0.57) PFKFB3ALDH1A1LMNAHPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2794009-A1 BISARYLSULFONAMIDES USEFUL IN THE TREATMENT OF INFLAMMATION AND CANCER Kancera AB (SE) 2014-10-29 EP claimed
WO-2013093095-A1 BISARYLSULFONAMIDES USEFUL IN THE TREATMENT OF INFLAMMATION AND CANCER KANCERA AB (SE) 2013-06-27 WO claimed
EP-2794009-A1 BISARYLSULFONAMIDES USEFUL IN THE TREATMENT OF INFLAMMATION AND CANCER Kancera AB (SE) 2014-10-29 EP disclosed
WO-2013093095-A1 BISARYLSULFONAMIDES USEFUL IN THE TREATMENT OF INFLAMMATION AND CANCER KANCERA AB (SE) 2013-06-27 WO disclosed